Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPTH Bio-Path Holdings, Inc.

休市中 07-26 16:00:00 EDT

1.77

+0.00

-0.24%

盘后1.77

+0.000.00%

16:00 EDT

最高1.82	最低1.73	成交量1.32万
今开1.76	昨收1.77	日振幅5.07%
总市值368.20万	流通市值367.47万	总股本208.02万
成交额2.33万	换手率0.63%	流通股本207.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPTH","market":"US","secType":"STK","nameCN":"Bio-Path Holdings, Inc.","latestPrice":1.77,"timestamp":1722024000000,"preClose":1.7743,"halted":0,"volume":13175,"hourTrading":{"tag":"盘后","latestPrice":1.77,"preClose":1.77,"latestTime":"16:00 EDT","volume":1,"amount":1.8,"timestamp":1722024030124},"delay":0,"floatShares":2076115,"shares":2080235,"eps":-25.84359,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0043,"latestTime":"07-26 16:00:00 EDT","open":1.76,"high":1.82,"low":1.7301,"amount":23349.136838,"amplitude":0.050668,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-25.84359,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"adjPreClose":1.7743,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.77,"preClose":1.77,"latestTime":"16:00 EDT","volume":1,"amount":1.8,"timestamp":1722024030124},"volumeRatio":0.37876174475019136,"impliedVol":6.8861,"impliedVolPercentile":0.9932},"requestUrl":"/m/hq/s/BPTH","defaultTab":"news","newsList":[{"id":"2452439754","title":"Bio-Path Holdings, Inc.盘中异动 快速下挫7.77%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439754","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452439754?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:57","pubTimestamp":1721318265,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时57分，Bio-Path Holdings, Inc.股票出现异动，股价急速跳水7.77%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为2.17%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2253.31%、2145.68%、1183.91%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235746aefa5a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235746aefa5a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2451181689","title":"Bio-Path Holdings, Inc.盘中异动 早盘大幅拉升5.63%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451181689","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451181689?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:04","pubTimestamp":1721138687,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时04分，Bio-Path Holdings, Inc.股票出现波动，股价快速拉升5.63%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1800.08%、1035.25%、96.35%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.19%、39.04%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716220448aef9f5a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716220448aef9f5a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2451962270","title":"Bio-Path Holdings, Inc.盘中异动 临近午盘股价大跌5.61%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451962270","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451962270?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:36","pubTimestamp":1721057760,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时36分，Bio-Path Holdings, Inc.股票出现异动，股价大幅跳水5.61%。截至发稿，该股报1.85美元/股，成交量1.7045万股，换手率0.82%，振幅7.65%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152336009f4fae5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152336009f4fae5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2450534860","title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450534860","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450534860?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:40","pubTimestamp":1720795227,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时40分，Bio-Path Holdings, Inc.股票出现异动，股价快速拉升5.31%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Soligenix, Inc.较为活跃，换手率分别为2590.08%、89.92%、49.86%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为147.88%、48.15%、47.50%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712224027aef97d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712224027aef97d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2450985842","title":"Bio-Path Holdings, Inc.盘中异动 下午盘快速上涨7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450985842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450985842?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:16","pubTimestamp":1720639007,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时16分，Bio-Path Holdings, Inc.股票出现波动，股价急速上涨7.93%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Kazia Therapeutics Limited、Uniqure N.V.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为4194.87%、1582.50%、1391.22%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为421.88%、156.03%、133.16%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110316489681b99b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110316489681b99b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2450073372","title":"Bio-Path Holdings, Inc.盘中异动 急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450073372","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450073372?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:51","pubTimestamp":1720543891,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时51分，Bio-Path Holdings, Inc.股票出现波动，股价快速下挫5.03%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Soligenix, Inc.、180 Life Sciences Corp.、Uniqure N.V.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为10229.02%、2549.08%、332.41%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为327.50%、196.29%、134.00%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005131941f57a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005131941f57a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2449097607","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨8.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449097607","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449097607?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:33","pubTimestamp":1720449210,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时33分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨8.19%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为1979.51%、171.59%、139.57%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Cero Therapeutics Holdings, Inc.，振幅分别为93.43%、46.35%、36.60%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223330941f4f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223330941f4f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2448160749","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌6.00%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448160749","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448160749?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:19","pubTimestamp":1719843549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时19分，Bio-Path Holdings, Inc.股票出现波动，股价急速跳水6.00%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为371.64%、120.20%、91.20%，振幅较大的相关个股有Senti Biosciences, Inc.、Seastar Medical Holding Corporation、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为101.49%、31.27%、28.78%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221910941f2c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701221910941f2c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2446304310","title":"Bio-Path Holdings, Inc.盘中异动 下午盘急速下挫7.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446304310","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446304310?lang=zh_cn&edition=full","pubTime":"2024-06-27 03:14","pubTimestamp":1719429282,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日03时14分，Bio-Path Holdings, Inc.股票出现异动，股价快速跳水7.14%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为776.39%、166.49%、124.58%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为115.15%、51.85%、50.25%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627031442941f1736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627031442941f1736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2446607841","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌5.10%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446607841","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446607841?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:45","pubTimestamp":1719323110,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时45分，Bio-Path Holdings, Inc.股票出现异动，股价大幅下挫5.10%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Effector Therapeutics, Inc.涨幅较大，Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为113.56%、93.54%、68.91%，振幅较大的相关个股有Werewolf Therapeutics, Inc.、Glycomimetics, Inc.、Cingulate Inc.，振幅分别为29.12%、23.37%、19.77%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625214510941f0ef9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625214510941f0ef9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2445122798","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445122798","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445122798?lang=zh_cn&edition=full","pubTime":"2024-06-22 01:24","pubTimestamp":1718990683,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日01时24分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫5.91%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 、Sarepta Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为398.10%、292.56%、230.65%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为133.33%、70.10%、65.42%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622012443af8eaa5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622012443af8eaa5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2444245596","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444245596","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444245596?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:02","pubTimestamp":1718895738,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时02分，Bio-Path Holdings, Inc.股票出现异动，股价快速上涨5.73%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。消息层面，截至23时02分，《Roth MKM维持Bio-Path Holdings买入评级，维持目标价20美元》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620230219941efdd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620230219941efdd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2444605301","title":"Bio-Path Holdings, Inc.盘中异动 快速拉升6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444605301","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444605301?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:49","pubTimestamp":1718632178,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时49分，Bio-Path Holdings, Inc.股票出现异动，股价急速拉升6.02%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。消息层面，截至21时49分，《Roth MKM维持Bio-Path Holdings买入评级，维持目标价20美元》资讯为影响Bio-Path Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214938aef549a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214938aef549a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2443183630","title":"Bio-Path Holdings, Inc.盘中异动 下午盘急速跳水7.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443183630","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443183630?lang=zh_cn&edition=full","pubTime":"2024-06-14 03:25","pubTimestamp":1718306731,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日03时25分，Bio-Path Holdings, Inc.股票出现异动，股价快速跳水7.51%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大，Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2852.34%、1350.50%、157.04%，振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为102.21%、82.05%、74.62%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614032531af8d7252&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614032531af8d7252&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2442346957","title":"Bio-Path Holdings, Inc.盘中异动 大幅下跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442346957","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442346957?lang=zh_cn&edition=full","pubTime":"2024-06-12 03:33","pubTimestamp":1718134392,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日03时33分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.63%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Clearmind Medicine Inc.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为162.17%、73.91%、31.67%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为482.47%、375.81%、85.71%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612033313968136eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612033313968136eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2442842590","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌5.18%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442842590","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442842590?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:31","pubTimestamp":1718026265,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时31分，Bio-Path Holdings, Inc.股票出现异动，股价急速下跌5.18%。截至发稿，该股报2.35美元/股，成交量6674股，换手率0.36%，振幅0.34%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102131059681304f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102131059681304f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2441067745","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌7.15%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441067745","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441067745?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:01","pubTimestamp":1717772505,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日23时01分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌7.15%。截至发稿，该股报2.58美元/股，成交量5.3995万股，换手率2.94%，振幅6.47%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060723014696812f64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060723014696812f64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2441176187","title":"Bio-Path Holdings, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441176187","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441176187?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:31","pubTimestamp":1717680717,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时31分，Bio-Path Holdings, Inc.股票出现波动，股价快速下跌5.35%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Virax Biolabs Group Limited、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1296.05%、73.27%、11.53%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Virax Biolabs Group Limited、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为54.74%、22.41%、9.97%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213157af8c6a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213157af8c6a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPTH"],"gpt_icon":0},{"id":"2440233109","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大跌17.34%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440233109","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440233109?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:31","pubTimestamp":1717507896,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时31分，Bio-Path Holdings, Inc.股票出现异动，股价大幅下挫17.34%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Equillium, Inc.较为活跃，换手率分别为35.24%、34.34%、19.86%，振幅较大的相关个股有康乃德生物、Fresh2 Group Limited、Silo Pharma, Inc.，振幅分别为14.03%、10.59%、10.34%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213136958d9215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213136958d9215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0},{"id":"2439845915","title":"Bio-Path Holdings, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439845915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439845915?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:37","pubTimestamp":1717166243,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时37分，Bio-Path Holdings, Inc.股票出现异动，股价快速拉升5.07%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Genprex, Inc.较为活跃，换手率分别为54.85%、30.02%、24.09%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vaccinex, Inc.，振幅分别为79.44%、50.12%、49.42%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053122372496811232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053122372496811232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPTH","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biopathholdings.com","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":-0.0969},{"period":"3month","weight":-0.3396},{"period":"6month","weight":-0.8117},{"period":"1year","weight":-0.9165},{"period":"ytd","weight":-0.8089}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-path Holdings, Inc.正处于发展阶段，其领先的治癌药物Liposomal Grb-2目前处于临床试验阶段。该公司在得克萨斯大学的附属医院安德森癌症研究中心的技术支持下成立，在特许协议下致力于研发新的抗癌药物。其拥有用于系统反义疗法的药物传输平台技术与知识产权。该公司还计划研究脂质体肿瘤定位技术，因为这一技术可以完善目前的传输技术，能进一步提高反义疗法的有效性。除了现有的技术专利，该公司将保持与安德森研究中心主要成员的紧密合作关系，因为后者将来可能为该公司提供潜在药物。该公司还希望将其技术扩展到反义药物之外的抗癌药物，包括安德森研究中心之外的机构所提供的候选药物。该公司成立于2007年5月10日。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.055835},{"month":2,"riseRate":0.4,"avgChangeRate":0.01406},{"month":3,"riseRate":0.6,"avgChangeRate":0.683886},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.127567},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.053526},{"month":6,"riseRate":0.545455,"avgChangeRate":0.01417},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.097205},{"month":8,"riseRate":0.3,"avgChangeRate":-0.14864},{"month":9,"riseRate":0.2,"avgChangeRate":-0.092335},{"month":10,"riseRate":0.6,"avgChangeRate":0.094767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.112549},{"month":12,"riseRate":0.4,"avgChangeRate":-0.110282}],"exchange":"NASDAQ","name":"Bio-Path Holdings, Inc.","nameEN":"Bio-Path"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio-Path Holdings, Inc.,BPTH,Bio-Path Holdings, Inc.股票,Bio-Path Holdings, Inc.股票老虎,Bio-Path Holdings, Inc.股票老虎国际,Bio-Path Holdings, Inc.行情,Bio-Path Holdings, Inc.股票行情,Bio-Path Holdings, Inc.股价,Bio-Path Holdings, Inc.股市,Bio-Path Holdings, Inc.股票价格,Bio-Path Holdings, Inc.股票交易,Bio-Path Holdings, Inc.股票购买,Bio-Path Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio-Path Holdings, Inc.(BPTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio-Path Holdings, Inc.(BPTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况